We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ATLANTA, GA -- (Marketwire) -- 10/10/08 -- AtheroGenics, Inc. (NASDAQ: AGIX) today reported that it received notification from the Nasdaq Stock Market indicating that the staff of the Nasdaq...
ATLANTA, GA -- (Marketwire) -- 10/07/08 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it has...
ATLANTA, GA -- (Marketwire) -- 09/10/08 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it has...
TORONTO -- (Marketwire) -- 09/02/08 -- BellwetherReport.com is the leading online financial newsletter for investors seeking top independent and unbiased research. Investors seeking free and...
ATLANTA, GA -- (Marketwire) -- 09/02/08 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today reported that it will not...
ATLANTA, GA , a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today reported financial results for the second quarter and six months ended June 30, 2008. During...
DALLAS, Aug. 1 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trading notes for free by visiting:...
TORONTO , Akamai Technologies Inc. (NASDAQ: AKAM), Starbucks Corporation (NASDAQ: SBUX) and Atherogenics Inc. (NASDAQ: AGIX). To receive free access to these interviews and analyst reports sign up...
ATLANTA, GA , a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced top-line results from its ANDES Phase 3 clinical trial of AGI-1067 (succinobucol...
ATLANTA, GA , a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it will release its second quarter 2008 financial results on Tuesday, August...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.69 | -2.33898305085 | 29.5 | 29.5 | 28.2 | 10823 | 28.62956943 | SP |
4 | -1.15 | -3.83845126836 | 29.96 | 30.37 | 28.2 | 11431 | 29.29642041 | SP |
12 | 2.55 | 9.71058644326 | 26.26 | 30.37 | 25.77 | 6739 | 28.53032523 | SP |
26 | 3.45 | 13.6041009464 | 25.36 | 30.37 | 21.82 | 5772 | 26.71116675 | SP |
52 | 3.45 | 13.6041009464 | 25.36 | 30.37 | 21.82 | 5772 | 26.71116675 | SP |
156 | 3.45 | 13.6041009464 | 25.36 | 30.37 | 21.82 | 5772 | 26.71116675 | SP |
260 | 3.45 | 13.6041009464 | 25.36 | 30.37 | 21.82 | 5772 | 26.71116675 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions